Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Cacciapuoti

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Therapeutic Advances in Gastroenterology|March 5, 2025
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialistsOlga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Journal of Clinical Medicine|May 11, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter StudyMatteo Megna, Anna Balato, Stefano Caccavale, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
International Journal of Dermatology|January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohortRiccardo Viola, Luca Mastorino, Matteo Megna, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Therapeutic Advances in Gastroenterology|March 5, 2025
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialistsOlga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Journal of Clinical Medicine|May 11, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter StudyMatteo Megna, Anna Balato, Stefano Caccavale, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
International Journal of Dermatology|January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohortRiccardo Viola, Luca Mastorino, Matteo Megna, et al.
Pageof 9